Abstract:Cyanobacteria are photosynthetic microorganisms that colonize diverse environments worldwide, ranging from ocean to freshwaters, soils, and extreme environments. Their adaptation capacities and the diversity of natural products that they synthesize, support cyanobacterial success in colonization of their respective ecological niches. Although cyanobacteria are well-known for their toxin production and their relative deleterious consequences, they also produce a large variety of molecules that exhibit beneficial properties with high potential in various fields (e.g., a synthetic analog of dolastatin 10 is used against Hodgkin’s lymphoma). The present review focuses on the beneficial activities of cyanobacterial molecules described so far. Based on an analysis of 670 papers, it appears that more than 90 genera of cyanobacteria have been observed to produce compounds with potentially beneficial activities in which most of them belong to the orders Oscillatoriales, Nostocales, Chroococcales, and Synechococcales. The rest of the cyanobacterial orders (i.e., Pleurocapsales, Chroococcidiopsales, and Gloeobacterales) remain poorly explored in terms of their molecular diversity and relative bioactivity. The diverse cyanobacterial metabolites possessing beneficial bioactivities belong to 10 different chemical classes (alkaloids, depsipeptides, lipopeptides, macrolides/lactones, peptides, terpenes, polysaccharides, lipids, polyketides, and others) that exhibit 14 major kinds of bioactivity. However, no direct relationship between the chemical class and the respective bioactivity of these molecules has been demonstrated. We further selected and specifically described 47 molecule families according to their respective bioactivities and their potential uses in pharmacology, cosmetology, agriculture, or other specific fields of interest. With this up-to-date review, we attempt to present new perspectives for the rational discovery of novel cyanobacterial metabolites with beneficial bioactivity.

The Chemistry, Biochemistry and Pharmacology of Marine Natural Products from Leptolyngbya, a Chemically Endowed Genus of Cyanobacteria

Bioactive Metabolites From Marine Microorganisms

Investigating the Biosynthesis of Natural Products from Marine Proteobacteria: A Survey of Molecules and Strategies

Natural Products from Cyanobacteria: Focus on Beneficial Activities

Chemically Diverse and Biologically Active Secondary Metabolites from Marine Phylum Chlorophyta

The Chemistry and Bioactivity of Macrolides from Marine Microorganisms

Secondary Metabolites from Marine Micromonospora: Chemistry and Bioactivities

Advances in Biosynthesis of Natural Products from Marine Microorganisms

Secondary metabolites from cyanobacteria: source, chemistry, bioactivities, biosynthesis and total synthesis

Review of Marine Cyanobacteria and the Aspects Related to Their Roles: Chemical, Biological Properties, Nitrogen Fixation and Climate Change

Secondary Metabolites from Marine <i>Micromonospora</i>: Chemistry and Bioactivities

Chemistry and bioactivity of secondary metabolites from South China Sea marine fauna and flora: recent research advances and perspective

Global analysis of the biosynthetic chemical space of marine prokaryotes

Marine drugs--macrolactins.

Secondary Metabolites from Marine-Derived Bacillus: A Comprehensive Review of Origins, Structures, and Bioactivities

Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications

Review of Bioactive Secondary Metabolites from Marine Bryozoans in the Progress of New Drugs Discovery

Minireview: Bioactive Compounds from Marine Bacteria and Fungi: Marine Bioactive Compounds

Secondary metabolites of marine-derived actinomycete microbes and their bioactivities

Structural Diversity, Biological Properties and Applications of Natural Products from Cyanobacteria. A Review

Marine Actinobacteria, an Important Source of Novel Secondary Metabolites with Bioactivities